Provenienza dei contatti di primo grado di Per Erik Sørensen
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Per Erik Sørensen tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Erasmus University Rotterdam | College/University | Masters Business Admin | |
Freie Universität Berlin | College/University | Doctorate Degree | |
PDL BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Aston | College/University | Doctorate Degree | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
All India Institute of Medical Sciences | College/University | Doctorate Degree | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Operating Officer | |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Corporate Officer/Principal | |
Nirvan Consultants LLC | President | ||
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chairman | |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Pharmaceuticals: Major | Director/Board Member | |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Biotechnology | Founder | |
Specialized Medical Services-Oncology BV
Specialized Medical Services-Oncology BV Miscellaneous Commercial ServicesCommercial Services Specialized Medical Services-Oncology BV engages in the provision of oncology solutions. It offers drug development affairs, medical writing, clinical operations, regulatory affairs, medical affairs, pharmacovigilance, biometrics, insights, and analytics services. The company was founded by Erik Leferink and Edwin Klumper in 2007 and is headquartered in Schiphol, the Netherlands. | Miscellaneous Commercial Services | Founder | |
Rgenta Therapeutics, Inc.
Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Rgenta Therapeutics, Inc. manufactures medicines for oncology and neurological disorders. The company was founded by Simon Xi, Travis Wager, and Zhiping Weng and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman | |
Pilatus Holding BV
Pilatus Holding BV Investment ManagersFinance Pilatus Holding BV provides wealth management and consulting services. The private company is based in Amstelveen, Netherlands. | Investment Managers | Director/Board Member | |
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Monopteros Therapeutics, Inc.
Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member | |
PASITHEA THERAPEUTICS CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alpha-5 Integrin LLC
Alpha-5 Integrin LLC Pharmaceuticals: MajorHealth Technology Part of Pasithea Therapeutics Corp., Alpha-5 Integrin LLC is a company that develops monoclonal antibody for the treatment of amyotrophic lateral sclerosis and neurodegenerative diseases. The company is based in South San Francisco, CA. The CEO of the company is Graeme Currie. Alpha-5 Integrin was acquired by Pasithea Therapeutics Corp. on June 22, 2022 for $3.29 million. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 18 |
Paesi Bassi | 4 |
Germania | 3 |
Belgio | 3 |
Regno Unito | 2 |
Settori
Health Technology | 20 |
Consumer Services | 5 |
Commercial Services | 3 |
Health Services | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 9 |
Corporate Officer/Principal | 8 |
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 3 |
Chairman | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Per Erik Sørensen
- Connessioni Società